Breast Cancer Research - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz, Laura C Collins

Luminal B breast tumors are not HER2 positive – authors' response

Rulla M Tamimi, Stuart J Schnitt, Graham A Colditz, Laura C Collins

Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer

E Thirthagiri, SY Lee, P Kang, DS Lee, GT Toh, S Selamat, S-Y Yoon, NA Mohd Taib, MK Thong, CH Yip, SH Teo

Molecular targeted therapies for breast cancer treatment

Claus M Schlotter, Ulf Vogt, Heike Allgayer, Burkhard Brandt

The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer

Chantal C Orgéas, Per Hall, Lena U Rosenberg, Kamila Czene

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

Alexandra M Pietersen, Hugo M Horlings, Michael Hauptmann, Anita Langer？d, Abderrahim Ajouaou, Paulien Cornelissen-Steijger, Lodewijk F Wessels, Jos Jonkers, Marc Vijver, Maarten van Lohuizen

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

Anna L Stratford, Christopher J Fry, Curtis Desilets, Alastair H Davies, Yong Y Cho, Yvonne Li, Zigang Dong, Isabelle M Berquin, Philippe P Roux, Sandra E Dunn

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines

XingWu Zhu, Lori A Mulcahy, Rabab AA Mohammed, Andrew HS Lee, Hester A Franks, Laura Kilpatrick, Acelya Yilmazer, E Claire Paish, Ian O Ellis, Poulam M Patel, Andrew M Jackson

Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells

Annabel C Borley, Stephen Hiscox, Julia Gee, Chris Smith, Victoria Shaw, Peter Barrett-Lee, Robert I Nicholson

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer

Fabien Reyal, Martin H van Vliet, Nicola J Armstrong, Hugo M Horlings, Karin E de Visser, Marlen Kok, Andrew E Teschendorff, Stella Mook, Laura van 't Veer, Carlos Caldas, Remy J Salmon, Marc Vijver, Lodewyk FA Wessels

Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies

Linda E Kelemen, Fergus J Couch, Shahana Ahmed, Alison M Dunning, Paul DP Pharoah, Douglas F Easton, Zachary S Fredericksen, Robert A Vierkant, V Shane Pankratz, Ellen L Goode, Christopher G Scott, David N Rider, Xianshu Wang, James R Cerhan, Celine M Vachon

The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer

William Tapper, Victoria Hammond, Sue Gerty, Sarah Ennis, Peter Simmonds, Andrew Collins, the Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) Steering Group, Diana Eccles

Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide

Kannan Krishnamurthy, Guanghu Wang, Dmitriy Rokhfeld, Erhard Bieberich

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda

Bettina Meiser, Kathy Tucker, Michael Friedlander, Kristine Barlow-Stewart, Elizabeth Lobb, Christobel Saunders, Gillian Mitchell

Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells

Yvonne Radestock, Cuong Hoang-Vu, Sabine Hombach-Klonisch

Variable size computer-aided detection prompts and mammography film reader decisions

Fiona J Gilbert, Susan M Astley, Caroline RM Boggis, Magnus A McGee, Pamela M Griffiths, Stephen W Duffy, Olorunsola F Agbaje, Maureen GC Gillan, Mary Wilson, Anil K Jain, Nicola Barr, Ursula M Beetles, Miriam A Griffiths, Jill Johnson, Rita M Roberts, Heather E Deans, Karen A Duncan, Geeta Iyengar

Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials

Sibylle Loibl, Gunter von Minckwitz, Nadia Harbeck, Wolfgang Janni, Dirk Elling, Manfred Kaufmann, Holm Eggemann, Valentina Nekljudova, Harald Sommer, Marion Kiechle, Sherko Kümmel

Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer

Katja Lundgren, Karolina Holm, Bo Nordenskj？ld, ？ke Borg, G？ran Landberg

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

Julie A Vendrell, Katherine E Robertson, Patrice Ravel, Susan E Bray, Agathe Bajard, Colin A Purdie, Catherine Nguyen, Sirwan M Hadad, Ivan Bieche, Sylvie Chabaud, Thomas Bachelot, Alastair M Thompson, Pascale A Cohen

Recurrence dynamics does not depend on the recurrence site

Romano Demicheli, Elia Biganzoli, Patrizia Boracchi, Marco Greco, Michael W Retsky

Selective segregation of DNA strands persists in long label retaining mammary cells during pregnancy

Brian W Booth, Corinne A Boulanger, Gilbert H Smith

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

Cornelia Liedtke, Luca Cardone, Attila Tordai, Kai Yan, Henry L Gomez, Luis Figureoa, Rebekah E Hubbard, Vicente Valero, Eduardo A Souchon, W Fraser Symmans, Gabriel N Hortobagyi, Alberto Bardelli, Lajos Pusztai

Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study

Heather Ward, Gaelle Chapelais, Gunter GC Kuhnle, Robert Luben, Kay-Tee Khaw, Sheila Bingham

Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene

Jennifer K Hockings, Stephanie C Degner, Sherif S Morgan, Michael Q Kemp, Donato F Romagnolo

Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case against

David A Cameron

Evaluation of biological pathways involved in chemotherapy response in breast cancer

Attila Tordai, Jing Wang, Fabrice Andre, Cornelia Liedtke, Kai Yan, Christos Sotiriou, Gabriel N Hortobagyi, W Fraser Symmans, Lajos Pusztai

Prognostic ability of a panel of immunohistochemistry markers – retailoring of an 'old solution'

Donal J Brennan, William M Gallagher

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction

Yu Tai, Sining Chen, Giovanni Parmigiani, Alison P Klein

The utility of conventional and molecular pathology in managing breast cancer

D Craig Allred

NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models

Michael Jensen, Joseph Schoepfer, Thomas Radimerski, Andrew Massey, Chantale T Guy, Josef Brueggen, Cornelia Quadt, Alan Buckler, Robert Cozens, Martin J Drysdale, Carlos Garcia-Echeverria, Patrick Chène

Introduction to the sessions on 'Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors'

Lesley Fallowfield, David George

Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer

Yasmine Nadler, Robert L Camp, Jennifer M Giltnane, Christopher Moeder, David L Rimm, Harriet M Kluger, Yuval Kluger

Breast cancer metastasis: a microRNA story

Massimo Negrini, George Calin

Tissue factor, angiogenesis and tumour progression

Joanne E Bluff, Nicola J Brown, Malcolm WR Reed, Carolyn A Staton

Inflammation and breast cancer. Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer

Carlo V Hojilla, Geoffrey A Wood, Rama Khokha

Cancer and fertility preservation: fertility preservation in breast cancer patients

Theodoros Maltaris, Michael Weigel, Andreas Mueller, Marcus Schmidt, Rudolf Seufert, Franz Fischl, Heinz Koelbl, Ralf Dittrich

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome

Alison J Butt, C Marcelo Sergio, Claire K Inman, Luke R Anderson, Catriona M McNeil, Amanda J Russell, Marco Nousch, Thomas Preiss, Andrew V Biankin, Robert L Sutherland, Elizabeth A Musgrove

Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients

Eunjung Lee, Roberta McKean-Cowdin, Huiyan Ma, Zhengjia Chen, David Van Den Berg, Brian E Henderson, Leslie Bernstein, Giske Ursin

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

Gunter von Minckwitz, Hans-Peter Sinn, Günter Raab, Sibylle Loibl, Jens-Uwe Blohmer, Holger Eidtmann, J？rn Hilfrich, Elisabeth Merkle, Christian Jackisch, Serban D Costa, Angelika Caputo, Manfred Kaufmann, the German Breast Group (GBG)

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis

Yiyu Zou, Wen-Bin Tsai, Chien-Jui Cheng, Chiun Hsu, Young Chung, Pao-Chen Li, Sue-Hwa Lin, Mickey CT Hu

Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)

Alexander Wall, Thorsten Persigehl, Peter Hauff, Kai Licha, Michael Schirner, Silke Müller, Angelika von Wallbrunn, Lars Matuszewski, Walter Heindel, Christoph Bremer

Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials

Marianne Kyndi, Flemming B S？rensen, Helle Knudsen, Jan Alsner, Marie Overgaard, Hanne M Nielsen, Jens Overgaard

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

Christine M Fillmore, Charlotte Kuperwasser

Evaluation of the current knowledge limitations in breast cancer research: a gap analysis

Alastair Thompson, Keith Brennan, Angela Cox, Julia Gee, Diana Harcourt, Adrian Harris, Michelle Harvie, Ingunn Holen, Anthony Howell, Robert Nicholson, Michael Steel, Charles Streuli, Breast Cancer Campaign Gap Analysis Meeting (2 November 2006, London, UK)

Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer

László Tabar, Peter B Dean

Introduction to sessions on 'What can surgeons do for us (and we for them): radiology, pathology, molecular biology and local therapy'

J Michael Dixon, Monica Morrow

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

Tanja Fehm, Volkmar Müller, Catherine Alix-Panabières, Klaus Pantel

NRG1 is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene

Y-L Chua, Y Ito, JCM Pole, S-F Chin, IO Ellis, C Caldas, MJ O'Hare, AM Murrell, PAW Edwards

Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case for

J Michael Dixon, David A Montgomery

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705